<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
<predicate lemma="splice">
<roleset id="splice.01" name="" wordnet="3">
<roles>
  <role n="0" descr="gene or RNA						
"/>
  <role n="1" descr="specific component in gene/RNA to get spliced			// eg. extron, intron //
"/>
  <role n="2" descr="gene product							// mRNA //
"/>
  <role n="3" descr="location referring to organelle, cell or tissue
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
Consequently, exon 30 with the intron is spliced.  

</text>
       <arg n="0">-	
</arg>
       <arg n="1">exon 30 with the intron
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
         1	Consequently	consequently		@ADVL %EH ADV
         2	,	,
         3	exon	exon	subj:&gt;5	@SUBJ %NH N NOM SG
         4	30	30	mod:&gt;3	@&lt;NOM %N&lt; NUM CARD
         5	is	be	v-ch:&gt;6	@+FAUXV %AUX V PRES SG3
         6	spliced	splice	main:&gt;0	@-FMAINV %VP EN
         7	together	together	meta:&gt;6	@ADVL %EH ADV
         8	with	with	com:&gt;6	@ADVL %EH PREP
         9	the	the	det:&gt;10	@DN&gt; %&gt;N DET
         10	intron	intron	pcomp:&gt;8	@&lt;P %NH N NOM SG
         11	.     .
</fdg>
</example>
<example src="MEDLINE" no="2">
<text>
The structure of different cDNA clones indicates that USF RNA is differentially spliced, and alternative exon usage may regulate the levels of functional USF protein.

</text>
       <arg n="0">USF RNA
</arg>
       <arg n="1">-
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
1	The	the	det:&gt;2	@DN&gt; %&gt;N DET
2	structure	structure	subj:&gt;7	@SUBJ %NH N NOM SG
3	of	of	mod:&gt;2	@&lt;NOM-OF %N&lt; PREP
4	different	different	attr:&gt;5	@A&gt; %&gt;N A ABS
5	cDNA	cdna	attr:&gt;6	@A&gt; %&gt;N ABBR NOM SG
6	clones	clone	pcomp:&gt;3	@&lt;P %NH N NOM PL
7	indicates	indicate	main:&gt;0	@+FMAINV %VA V PRES SG3
8	that	that	pm:&gt;13	@CS %CS CS
9	USF	usf	subj:&gt;11	@SUBJ %NH N NOM SG
10	RNA	rna	mod:&gt;9	@&lt;NOM %N&lt; ABBR NOM SG
11	is	be	v-ch:&gt;13	@+FAUXV %AUX V PRES SG3
12	differentially	differentially	meta:&gt;13	@ADVL %EH ADV
13	spliced	splice	obj:&gt;7	@-FMAINV %VP EN
14	,	,
15	and	and	cc:&gt;13	@CC %CC CC
16	alternative	alternative	attr:&gt;17	@A&gt; %&gt;N A ABS
17	exon	exon	attr:&gt;18	@A&gt; %&gt;N N NOM SG
18	usage	usage	subj:&gt;19	@SUBJ %NH N NOM SG
19	may	may	v-ch:&gt;20	@+FAUXV %AUX V AUXMOD
20	regulate	regulate	cc:&gt;13	@-FMAINV %VA V INF
21	the	the	det:&gt;22	@DN&gt; %&gt;N DET
22	levels	level	obj:&gt;20	@OBJ %NH N NOM PL
23	of	of	mod:&gt;22	@&lt;NOM-OF %N&lt; PREP
24	functional	functional	attr:&gt;25	@A&gt; %&gt;N A ABS
25	USF	usf	attr:&gt;26	@A&gt; %&gt;N N NOM SG
26	protein	protein	pcomp:&gt;23	@&lt;P %NH N NOM SG
27	.     .
</fdg>
</example>
<example src="MEDLINE" no="3">
<text>
We also identified four transcriptional units that are spliced but contain no obvious open reading frame. 

</text>
       <arg n="0">four transcriptional units
</arg>
       <arg n="1">-
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
         1	We	we	subj:&gt;3	@SUBJ %NH PRON PERS NOM PL1
         2	also	also	meta:&gt;3	@ADVL %EH ADV
         3	identified	identify	main:&gt;0	@+FMAINV %VA V PAST
         4	four	four	qn:&gt;6	@QN&gt; %&gt;N NUM CARD
         5	transcriptional	transcriptional	attr:&gt;6	@A&gt; %&gt;N A ABS
         6	units	unit	obj:&gt;3	@OBJ %NH N NOM PL
         7	that	that	subj:&gt;8	@SUBJ %NH &lt;Rel&gt; PRON
         8	are	be	v-ch:&gt;9	@+FAUXV %AUX V PRES
         9	spliced	splice	mod:&gt;6	@-FMAINV %VP EN
         10	but	but	cc:&gt;9	@CC %CC CC
         11	contain	contain	cc:&gt;9	@+FMAINV %VA V PRES
         12	no	no	det:&gt;16	@DN&gt; %&gt;N DET
         13	obvious	obvious	attr:&gt;14	@A&gt; %&gt;N A ABS
         14	open	open	attr:&gt;15	@A&gt; %&gt;N A ABS
         15	reading	reading	attr:&gt;16	@A&gt; %&gt;N N NOM SG
         16	frame	frame	obj:&gt;11	@OBJ %NH N NOM SG
         17	.     .
</fdg>
</example>
<example src="MEDLINE" no="*4">
<text>
The Supt4h gene is spliced normally from five exons encoded by chromosome 11.  

</text>
       <arg n="0">The Supt4h gene
</arg>
       <arg n="1">five exons encoded by chromosome 11
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
         1	The	the	det:&gt;3	@DN&gt; %&gt;N DET
         2	Supt4h	supt4h	attr:&gt;3	@A&gt; %&gt;N &lt;?&gt; N NOM SG
         3	gene	gene	subj:&gt;4	@SUBJ %NH N NOM SG
         4	is	be	v-ch:&gt;5	@+FAUXV %AUX V PRES SG3
         5	spliced	splice	main:&gt;0	@-FMAINV %VP EN
         6	normally	normally	man:&gt;5	@ADVL %EH ADV
         7	from	from	sou:&gt;5	@ADVL %EH PREP
         8	five	five	qn:&gt;9	@QN&gt; %&gt;N NUM CARD
         9	exons	exon	pcomp:&gt;7	@&lt;P %NH &lt;?&gt; N NOM PL
         10	encoded	encode	mod:&gt;9	@-FMAINV %VP EN
         11	by	by	ha:&gt;10	@ADVL %EH PREP
         12	chromosome	chromosome	attr:&gt;13	@A&gt; %&gt;N N NOM SG
         13	11	11	pcomp:&gt;11	@&lt;P %NH NUM CARD
         14	.     .
</fdg>
</example>
<example src="PNAS" no="1">
<text>
A caspase-2 minigene construct has been made that can be alternatively spliced in transfected cells and nuclear extracts.

</text>
       <arg n="0">A caspase-2 minigene construct 
</arg>
       <arg n="1">-
</arg>
       <arg n="2">-
</arg>
       <arg n="3">transfected cells and nuclear extracts
</arg>
<fdg>
1	A	a	det:&gt;4	@DN&gt; %&gt;N DET SG
2	caspase-2	caspase-2	qn:&gt;3	@QN&gt; %&gt;N &lt;?&gt; NUM CARD
3	minigene	minigene	attr:&gt;4	@A&gt; %&gt;N &lt;?&gt; N NOM SG
4	construct	construct	subj:&gt;5	@SUBJ %NH N NOM SG
5	has	have	v-ch:&gt;6	@+FAUXV %AUX V PRES SG3
6	been	be	v-ch:&gt;7	@-FAUXV %AUX EN
7	made	make		@-FMAINV %VP EN
8	that	that		@SUBJ %NH &lt;Rel&gt; PRON	@OBJ %NH &lt;Rel&gt; PRON	@PCOMPL-S %NH &lt;Rel&gt; PRON
9	can	can	v-ch:&gt;10	@+FAUXV %AUX V AUXMOD
10	be	be	v-ch:&gt;12	@-FAUXV %AUX V INF
11	alternatively	alternatively	meta:&gt;12	@ADVL %EH ADV
12	spliced	splice		@-FMAINV %VP EN
13	in	in	loc:&gt;12	@ADVL %EH PREP
14	transfected	transfected	attr:&gt;15	@A&gt; %&gt;N A ABS
15	cells	cell	pcomp:&gt;13	@&lt;P %NH N NOM PL
16	and	and	cc:&gt;13	@CC %CC CC
17	in	in	cc:&gt;13	@ADVL %EH PREP
18	nuclear	nuclear	attr:&gt;19	@A&gt; %&gt;N A ABS
19	extracts	extract	pcomp:&gt;17	@&lt;P %NH N NOM PL
20	.     .
</fdg>
</example>
<example src="PNAS" no="2">
<text>
The casp-2 minigene (C2) was spliced efficiently in vitro, and the ratio of casp-2S to casp-2L mRNAs produced was similar to the one observed in vivo (Fig.1 C, lane 1).

</text>
       <arg n="0">The casp-2 minigene (C2)
</arg>
       <arg n="1">-
</arg>
       <arg n="2">-
</arg>
       <arg n="3">vitro
</arg>
<fdg>
1	The	the	det:&gt;3	@DN&gt; %&gt;N DET
2	casp-2	casp-2	attr:&gt;3	@A&gt; %&gt;N &lt;?&gt; NUM CARD
3	minigene	minigene	subj:&gt;7	@SUBJ %NH &lt;?&gt; N NOM SG
4	(	(
5	C2	c2	mod:&gt;3	@NH %NH ABBR NOM SG
6	)	)
7	was	be	v-ch:&gt;8	@+FAUXV %AUX V PAST
8	spliced	splice	main:&gt;0	@-FMAINV %VP EN
9	efficiently	efficiently	man:&gt;8	@ADVL %EH ADV
10	in vitro	in vitro		@ADVL %EH ADV	@OBJ %NH A ABS	@&lt;NOM %N&lt; A ABS
11	,	,
12	and	and	cc:&gt;8	@CC %CC CC
13	the	the	det:&gt;14	@DN&gt; %&gt;N DET
14	ratio	ratio	subj:&gt;21	@SUBJ %NH N NOM SG
15	of	of	mod:&gt;14	@&lt;NOM-OF %N&lt; PREP
16	casp-2S	casp-2	pcomp:&gt;15	@&lt;P %NH &lt;?&gt; ABBR NOM PL
17	to	to	mod:&gt;16	@&lt;NOM %N&lt; PREP
18	casp-2L	casp-2l	attr:&gt;19	@A&gt; %&gt;N &lt;?&gt; N NOM SG
19	mRNAs	mrna	pcomp:&gt;17	@&lt;P %NH &lt;?&gt; N NOM PL
20	produced	produce	mod:&gt;19	@-FMAINV %VP EN
21	was	be	cc:&gt;8	@+FMAINV %VA V PAST
22	similar	similar	comp:&gt;21	@PCOMPL-S %NH A ABS
23	to	to	mod:&gt;22	@&lt;NOM %N&lt; PREP
24	the	the	det:&gt;25	@DN&gt; %&gt;N DET
25	one	one	pcomp:&gt;23	@&lt;P %NH PRON NOM SG
26	observed	observe	mod:&gt;25	@-FMAINV %VP EN
27	in vivo	in vivo	obj:&gt;26	@OBJ %NH A ABS
28	(	(
29	Fig.	fig.	attr:&gt;30	@A&gt; %&gt;N ABBR NOM SG
30	1	1	attr:&gt;31	@A&gt; %&gt;N NUM CARD
31	C	c	main:&gt;28	@APP %NH N NOM SG
32	,	,
33	lane	lane		@NH %NH N NOM SG	@APP %NH N NOM SG	@A&gt; %&gt;N N NOM SG	@&lt;P %NH N NOM SG
34	1	1		@NH %NH NUM CARD	@APP %NH NUM CARD	@&lt;P %NH NUM CARD	@A&gt; %&gt;N NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
35	)	)
36	.     .
</fdg>
</example>
<example src="PNAS" no="*3">
<text>
When incubated in nuclear extracts or transfected in HeLa cells, the C2Gloi2 substrate was spliced predominantly following the exon-skipping pathway to a level similar to that obtained with the C2 substrate (data not shown and Fig.2 E, compare lane 3 to lane 1).

</text>
       <arg n="0">the C2Gloi2 substrate 
</arg>
       <arg n="1">the exon-skipping pathway 
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
1	When	when	tmp:&gt;2	@ADVL %EH ADV WH
2	incubated	incubate	tmp:&gt;16	@-FMAINV %VP EN
3	in	in	ha:&gt;2	@ADVL %EH PREP
4	nuclear	nuclear	attr:&gt;5	@A&gt; %&gt;N A ABS
5	extracts	extract	pcomp:&gt;3	@&lt;P %NH N NOM PL
6	or	or	cc:&gt;2	@CC %CC CC
7	transfected	transfect	cc:&gt;2	@-FMAINV %VP EN
8	in	in	ha:&gt;7	@ADVL %EH PREP
9	HeLa	hela	attr:&gt;10	@A&gt; %&gt;N N NOM SG
10	cells	cell	pcomp:&gt;8	@&lt;P %NH N NOM PL
11	,	,
12	the	the	det:&gt;14	@DN&gt; %&gt;N DET
13	C2Gloi2	c2gloi2	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	substrate	substrate	subj:&gt;15	@SUBJ %NH N NOM SG
15	was	be	v-ch:&gt;16	@+FAUXV %AUX V PAST
16	spliced	splice	main:&gt;0	@-FMAINV %VP EN
17	predominantly	predominantly		@ADVL %EH ADV
18	following	follow	man:&gt;16	@-FMAINV %VA ING
19	the	the	det:&gt;21	@DN&gt; %&gt;N DET
20	exon-skipping	exon-skipping	attr:&gt;21	@A&gt; %&gt;N &lt;?&gt; A ABS
21	pathway	pathway	obj:&gt;18	@OBJ %NH N NOM SG
22	to	to	goa:&gt;18	@ADVL %EH PREP
23	a	a	det:&gt;25	@DN&gt; %&gt;N DET SG
24	level	level	attr:&gt;25	@A&gt; %&gt;N A ABS
25	similar	similar	pcomp:&gt;22	@&lt;P %NH A ABS
26	to	to	mod:&gt;25	@&lt;NOM %N&lt; PREP
27	that	that	pcomp:&gt;26	@&lt;P %NH PRON DEM SG
28	obtained	obtain	mod:&gt;27	@-FMAINV %VP EN
29	with	with	ha:&gt;28	@ADVL %EH PREP
30	the	the	det:&gt;32	@DN&gt; %&gt;N DET
31	C2	c2	attr:&gt;32	@A&gt; %&gt;N ABBR NOM SG
32	substrate	substrate	pcomp:&gt;29	@&lt;P %NH N NOM SG
33	(	(
34	data	data	obj:&gt;28	@OBJ %NH N NOM
35	not	not		@ADVL %EH NEG-PART
36	shown	show		@-FMAINV %VP EN
37	and	and		@CC %CC CC
38	Fig.	fig.	attr:&gt;39	@A&gt; %&gt;N ABBR NOM SG
39	2	2		@A&gt; %&gt;N NUM CARD
40	E	e		@NH %NH ABBR NOM SG	@SUBJ %NH ABBR NOM SG	@OBJ %NH ABBR NOM SG	@I-OBJ %NH ABBR NOM SG	@APP %NH ABBR NOM SG
41	,	,
42	compare	compare		@+FMAINV %VA V PRES	@-FMAINV %VA V INF	@&lt;P-FMAINV %VA V INF
43	lane	lane	obj:&gt;42	@OBJ %NH N NOM SG
44	3	3	qua:&gt;42	@ADVL %EH NUM CARD
45	to	to	goa:&gt;42	@ADVL %EH PREP
46	lane	lane	attr:&gt;47	@A&gt; %&gt;N N NOM SG
47	1	1	pcomp:&gt;45	@&lt;P %NH NUM CARD
48	)	)
49	.     .
</fdg>
</example>
<example src="PNAS" no="*4">
<text>
An additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most AG 6 nt further downstream such that RNA 3I spliced only 20% as efficiently as RNA 3F (Fig.1 C Left).

</text>
       <arg n="0">- 
</arg>
       <arg n="1">-
</arg>
       <arg n="2">RNA 3I 
</arg>
       <arg n="3">-
</arg>
<fdg>
1	An	an	det:&gt;3	@DN&gt; %&gt;N DET SG
2	additional	additional	attr:&gt;3	@A&gt; %&gt;N A ABS
3	observation	observation	main:&gt;0	@NH %NH N NOM SG
4	with	with	mod:&gt;3	@&lt;NOM %N&lt; PREP
5	the	the	det:&gt;6	@DN&gt; %&gt;N DET
6	tandem	tandem	pcomp:&gt;4	@&lt;P %NH N NOM SG
7	repeat-containing	repeat-contain*	mod:&gt;6	@-FMAINV %VA &lt;?&gt; ING
8	3	3	qua:&gt;7	@ADVL %EH NUM CARD
9	?	?
10	&lt;s&gt;	&lt;s&gt;
1	substrates	substrate	subj:&gt;2	@SUBJ %NH N NOM PL
2	was	be	main:&gt;0	@+FMAINV %VA V PAST
3	that	that	pm:&gt;10	@CS %CS CS
4	the	the	det:&gt;5	@DN&gt; %&gt;N DET
5	efficiency	efficiency	subj:&gt;10	@SUBJ %NH N NOM SG
6	of	of	mod:&gt;5	@&lt;NOM-OF %N&lt; PREP
7	bimolecular	bimolecular	attr:&gt;8	@A&gt; %&gt;N A ABS
8	exon	exon	attr:&gt;9	@A&gt; %&gt;N N NOM SG
9	ligation	ligation	pcomp:&gt;6	@&lt;P %NH N NOM SG
10	decreased	decrease	comp:&gt;2	@+FMAINV %VA V PAST
11	stepwise	stepwise		@ADVL %EH ADV	@AD-A&gt; %E&gt; ADV	@SUBJ %NH A ABS	@OBJ %NH A ABS	@&lt;NOM %N&lt; A ABS
12	with	with	ha:&gt;10	@ADVL %EH PREP
13	each	each	det:&gt;14	@DN&gt; %&gt;N DET SG
14	mutation	mutation	pcomp:&gt;12	@&lt;P %NH N NOM SG
15	that	that	subj:&gt;16	@SUBJ %NH &lt;Rel&gt; PRON
16	moved	move	mod:&gt;14	@+FMAINV %VA V PAST
17	the	the	det:&gt;18	@DN&gt; %&gt;N DET
18	5	5	obj:&gt;16	@OBJ %NH NUM CARD
19	?	?
20	&lt;s&gt;	&lt;s&gt;
1	-	-
2	most	many		@DN&gt; %&gt;N DET SUP PL	@DN&gt; %&gt;N DET SUP SG
3	AG	ag	attr:&gt;4	@A&gt; %&gt;N N NOM SG
4	6	6		@A&gt; %&gt;N NUM CARD
5	nt	nt		@SUBJ %NH ABBR NOM SG	@OBJ %NH ABBR NOM SG	@A&gt; %&gt;N ABBR NOM SG	@NH %NH ABBR NOM SG
6	further	further	det:&gt;7	@DN&gt; %&gt;N DET
7	downstream	downstream		@NH %NH N NOM SG	@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG	@PCOMPL-O %NH N NOM SG	@APP %NH N NOM SG	@ADVL %EH N NOM SG
8	such that	such that	pm:&gt;11	@CS %CS CS
9	RNA	rna	attr:&gt;10	@A&gt; %&gt;N ABBR NOM SG
10	3I	3i	subj:&gt;11	@SUBJ %NH N NOM SG
11	spliced	splice		@+FMAINV %VA V PAST
12	only	only		@ADVL %EH ADV	@AD-A&gt; %E&gt; ADV
13	20%	20%	qua:&gt;11	@ADVL %EH NUM CARD
14	as	as	ad:&gt;15	@AD-A&gt; %E&gt; ADV
15	efficiently	efficiently	man:&gt;11	@ADVL %EH ADV
16	as	as	mod:&gt;14	@ADVL %EH PREP
17	RNA	rna		@A&gt; %&gt;N ABBR NOM SG
18	3F	3f	mod:&gt;17	@&lt;NOM %N&lt; NUM CARD
19	(	(
20	Fig.	fig.	attr:&gt;21	@A&gt; %&gt;N ABBR NOM SG
21	1	1	attr:&gt;22	@A&gt; %&gt;N NUM CARD
22	C	c	subj:&gt;23	@SUBJ %NH N NOM SG
23	Left	leave		@+FMAINV %VA V PAST
24	)	)
25	.     .
</fdg>
</example>
<example src="PNAS" no="*5">
<text>
The pre-mRNAs from all of these genes are spliced with little or no exon-skipping (ref.16; also Fig.1 C and data not shown), suggesting that correct exon inclusion can be managed by the yeast gene expression machinery.

</text>
       <arg n="0">The pre-mRNAs from all of these genes
</arg>
       <arg n="1">little or no exon-skipping
</arg>
       <arg n="2">- 
</arg>
       <arg n="3">-
</arg>
<fdg>
1	The	the	det:&gt;2	@DN&gt; %&gt;N DET
2	pre-mRNAs	pre-mrna	subj:&gt;8	@SUBJ %NH &lt;?&gt; N NOM PL
3	from	from	mod:&gt;2	@&lt;NOM %N&lt; PREP
4	all	all	pcomp:&gt;3	@&lt;P %NH PRON
5	of	of	mod:&gt;4	@&lt;NOM-OF %N&lt; PREP
6	these	this	det:&gt;7	@DN&gt; %&gt;N DET DEM PL
7	genes	gene	pcomp:&gt;5	@&lt;P %NH N NOM PL
8	are	be	v-ch:&gt;9	@+FAUXV %AUX V PRES
9	spliced	splice	main:&gt;0	@-FMAINV %VP EN
10	with	with	ha:&gt;9	@ADVL %EH PREP
11	little or no	little or no	det:&gt;12	@DN&gt; %&gt;N DET
12	exon-skipping	exon-skipping	pcomp:&gt;10	@&lt;P %NH &lt;?&gt; A ABS
13	(	(
14	ref.	ref.		@OBJ %NH ABBR NOM SG	@NH %NH ABBR NOM SG
15	16	16	mod:&gt;14	@&lt;NOM %N&lt; NUM CARD
16	;	;
17	also	also		@ADVL %EH ADV
18	Fig.	fig.	attr:&gt;19	@A&gt; %&gt;N ABBR NOM SG
19	1	1	attr:&gt;20	@A&gt; %&gt;N NUM CARD
20	C	c	mod:&gt;15	@NH %NH N NOM SG
21	and	and	cc:&gt;20	@CC %CC CC
22	data	data	cc:&gt;20	@NH %NH N NOM
23	not	not	neg:&gt;24	@ADVL %EH NEG-PART
24	shown	show	mod:&gt;22	@-FMAINV %VP EN
25	)	)
26	,	,
27	suggesting	suggest	man:&gt;9	@-FMAINV %VA ING
28	that	that	pm:&gt;34	@CS %CS CS
29	correct	correct	attr:&gt;30	@A&gt; %&gt;N A ABS
30	exon	exon	attr:&gt;31	@A&gt; %&gt;N N NOM SG
31	inclusion	inclusion	subj:&gt;32	@SUBJ %NH N NOM SG
32	can	can	v-ch:&gt;33	@+FAUXV %AUX V AUXMOD
33	be	be	v-ch:&gt;34	@-FAUXV %AUX V INF
34	managed	manage	obj:&gt;27	@-FMAINV %VP EN
35	by	by	agt:&gt;34	@ADVL %EH PREP
36	the	the	det:&gt;40	@DN&gt; %&gt;N DET
37	yeast	yeast	attr:&gt;38	@A&gt; %&gt;N N NOM SG
38	gene	gene	attr:&gt;39	@A&gt; %&gt;N N NOM SG
39	expression	expression	attr:&gt;40	@A&gt; %&gt;N N NOM SG
40	machinery	machinery	pcomp:&gt;35	@&lt;P %NH N NOM SG
41	.     .
</fdg>
</example>
<example src="Virology" no="1">
<text>
However, a pre-mRNA containing mutations in SE2 is spliced predominantly using the nt 3605 3' splice site. 

</text>
       <arg n="0">a pre-mRNA containing mutations in SE2
</arg>
       <arg n="1">the nt 3605 3' splice site
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
<fdg>
1	However	however	meta:&gt;10	@ADVL %EH ADV WH
2	,	,
3	a	a	det:&gt;6	@DN&gt; %&gt;N DET SG
4	pre-mRNA	pre-mrna	attr:&gt;5	@A&gt; %&gt;N &lt;?&gt; A ABS
5	containing	containing	attr:&gt;6	@A&gt; %&gt;N A ABS
6	mutations	mutation	subj:&gt;9	@SUBJ %NH N NOM PL
7	in	in	mod:&gt;6	@&lt;NOM %N&lt; PREP
8	SE2	se2	pcomp:&gt;7	@&lt;P %NH N NOM SG
9	is	be	v-ch:&gt;10	@+FAUXV %AUX V PRES SG3
10	spliced	splice	main:&gt;0	@-FMAINV %VP EN
11	predominantly	predominantly		@ADVL %EH ADV
12	using	use	man:&gt;10	@-FMAINV %VA ING
13	the	the	det:&gt;14	@DN&gt; %&gt;N DET
14	nt	nt	obj:&gt;12	@OBJ %NH ABBR NOM SG
15	3605	3605	qn:&gt;16	@QN&gt; %&gt;N NUM CARD
16	3	3	qua:&gt;12	@ADVL %EH NUM CARD
17	?	?
18	&lt;s&gt;	&lt;s&gt;
1	splice	splice	main:&gt;0	@+FMAINV %VA V IMP
2	site	site	obj:&gt;1	@OBJ %NH N NOM SG
3	.     .
</fdg>
</example>
<example src="Nucleic Acid" no="1">
<text>
Vertebrate internal exons are usually between 50 and 400 nt long; exons outside this size range may require additional exonic and/or intronic sequences to be spliced into the mature mRNA.

</text>
       <arg n="0">-
</arg>
       <arg n="1">exons outside this size range
</arg>
       <arg n="2">the mature mRNA
</arg>
       <arg n="3">-
</arg>
<fdg>
1	Vertebrate	vertebrate	attr:&gt;2	@A&gt; %&gt;N N NOM SG
2	internal	internal	attr:&gt;3	@A&gt; %&gt;N A ABS
3	exons	exon	subj:&gt;4	@SUBJ %NH &lt;?&gt; N NOM PL
4	are	be	main:&gt;0	@+FMAINV %VA V PRES
5	usually	usually	man:&gt;4	@ADVL %EH ADV
6	between	between	ha:&gt;4	@ADVL %EH PREP
7	50	50	pcomp:&gt;6	@&lt;P %NH NUM CARD
8	and	and	cc:&gt;7	@CC %CC CC
9	400	400	cc:&gt;7	@&lt;P %NH NUM CARD
10	nt	nt	attr:&gt;11	@A&gt; %&gt;N ABBR NOM SG
11	long	long		@PCOMPL-S %NH A ABS
12	;	;
13	exons	exon	subj:&gt;18	@SUBJ %NH &lt;?&gt; N NOM PL
14	outside	outside	mod:&gt;13	@&lt;NOM %N&lt; PREP
15	this	this	det:&gt;17	@DN&gt; %&gt;N DET DEM SG
16	size	size	attr:&gt;17	@A&gt; %&gt;N N NOM SG
17	range	range	pcomp:&gt;14	@&lt;P %NH N NOM SG
18	may	may	v-ch:&gt;19	@+FAUXV %AUX V AUXMOD
19	require	require	cc:&gt;4	@-FMAINV %VA V INF
20	additional	additional	attr:&gt;21	@A&gt; %&gt;N A ABS
21	exonic	exonic	obj:&gt;19	@OBJ %NH &lt;?&gt; A ABS
22	and/or	and/or	cc:&gt;19	@CC %CC CC
23	intronic	intronic	subj:&gt;24	@SUBJ %NH &lt;?&gt; A ABS
24	sequences	sequence	cc:&gt;19	@+FMAINV %VA V PRES SG3
25	to	to	pm:&gt;26	@INFMARK&gt; %AUX INFMARK&gt;
26	be	be	v-ch:&gt;27	@-FAUXV %AUX V INF
27	spliced	splice	obj:&gt;24	@-FMAINV %VP EN
28	into	into	goa:&gt;27	@ADVL %EH PREP
29	the	the	det:&gt;31	@DN&gt; %&gt;N DET
30	mature	mature	attr:&gt;31	@A&gt; %&gt;N A ABS
31	mRNA	mrna	pcomp:&gt;28	@&lt;P %NH ABBR NOM SG
32	.     .
</fdg>
</example>
<example src="Nucleic Acid" no="2">
<text>
The mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is efficiently spliced into the mRNA.

</text>
       <arg n="0">-
</arg>
       <arg n="1">a 654 nt exon 
</arg>
       <arg n="2">the mRNA 
</arg>
       <arg n="3">-
</arg>
<fdg>
1	The	the	det:&gt;6	@DN&gt; %&gt;N DET
2	mouse	mouse	attr:&gt;3	@A&gt; %&gt;N N NOM SG
3	polymeric	polymeric	attr:&gt;4	@A&gt; %&gt;N A ABS
4	immunoglobulin	immunoglobulin	attr:&gt;5	@A&gt; %&gt;N N NOM SG
5	receptor	receptor	attr:&gt;6	@A&gt; %&gt;N N NOM SG
6	gene	gene	subj:&gt;7	@SUBJ %NH N NOM SG
7	has	have	main:&gt;0	@+FMAINV %VA V PRES SG3
8	a	a	det:&gt;9	@DN&gt; %&gt;N DET SG
9	654	654	obj:&gt;7	@OBJ %NH NUM CARD
10	nt	nt	attr:&gt;11	@A&gt; %&gt;N ABBR NOM SG
11	exon	exon		@SUBJ %NH N NOM SG	@OBJ %NH N NOM SG
12	that	that	subj:&gt;13	@SUBJ %NH &lt;Rel&gt; PRON
13	is	be	v-ch:&gt;15	@+FAUXV %AUX V PRES SG3
14	efficiently	efficiently	meta:&gt;15	@ADVL %EH ADV
15	spliced	splice	mod:&gt;11	@-FMAINV %VP EN
16	into	into	goa:&gt;15	@ADVL %EH PREP
17	the	the	det:&gt;18	@DN&gt; %&gt;N DET
18	mRNA	mrna	pcomp:&gt;16	@&lt;P %NH ABBR NOM SG
19	.     .
</fdg>
</example>
</roleset>
</predicate>
</frameset>
